High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of kenyan women infected with human immunodeficiency virus

Journal of Medical Virology

Volumn 83, Issue 11, 2011, Pages 1988-1996

  Rahman, Mosfequr ^a   Sasagawa, Toshiyuki ^a   Yamada, Rika ^b   Kingoro, Alan ^c   Ichimura, Hiroshi ^d   Makinoda, Satoru ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; HPV genotype; Human immunodeficiency virus (HIV); Human papillomavirus (HPV); Immunity; Kenya

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMA VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 52; KENYA; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; UTERINE CERVICITIS; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADULT; CERVIX UTERI; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HIV; HIV INFECTIONS; HUMANS; KENYA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; VAGINAL SMEARS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 80052757614     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22203     Document Type: Article

References (39)

1. Adachi A, Fleming I, Burk RD, Ho GY, Klein RS. 1993. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: A prospective study of colposcopy and clinical outcome. Obstet Gynecol 81: 372-377.
2. Barun L. 1994. Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated neoplasia. Am J Pathol 144: 209-214.
3. Berrebi A, Badiou W, Duclusaud A. 2008. Frequency, persistence and recurrence of HIV lesions of the uterine cervix in HIV-positive women. Gynecol Obstet Fertil 36: 521-524.
4. Blossom DB, Beigi RH, Farrel JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, Whalen CC, Salata RA. 2007. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol 79: 758-765.
5. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kuraman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802.
6. Bradbeer C. 1987. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? Lancet 2: 1277-1278.
7. Byrne MA, Taylor-Robinson D, Munday PE, Harris JRW. 1989. The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 3: 379-382.
8. Chiasson MA, Ellerbrock TV, Bush TJ, Sun XW, Wright TC, Jr. 1997. Increased prevalence of vulvovaginal condyloma and vulver intraepithelial neoplasia in women infected with human immunodeficiency virus. Obstet Gynecol 89: 690-694.
9. Clifford GM, Goncalves MA, Franceschi S. 2006. Human papillomavirus types among women infected with HIV: A meta-analysis. AIDS 20: 2337-2344.
10. Denny L, Boa R, Williamson AL, Allan B, Hardie D, Stan R, Myer L. 2008. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1 infected women. Obstet Gynecol 111: 1380-1387.
11. Ermel A, Qadadri B, Morishita A, Miyagawa I, Yamazaki G, Weaver B, Tu W, Tong Y, Randolph M, Cramer H, Brown D. 2010. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay. J Virol Methods 169: 154-161 [Epub July 27, 2010].
12. Feingold AR, Vermund SH, Burk RD, Kelley KF, Schrager LK, Schreiber K, et al. 1990. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 3: 896-903.
13. Frisch AL, Bigger RJ, Goedert JJ. 2000. Human papillomavirus-associated cancers in a patient with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92: 1500-1510.
14. Fruchter RG, Maiman M, Arrastia CD, Matthews R, Gates EJ, Holcomb K. 1998. Is HIV infection a risk factor for advanced cervical cancer? J Acquir Immune Defic Syndr Hum Retrovirol 18: 241-245.
15. Hawes SE, Critchlow CW, Sow PS, Tourep N, Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB. 2006. Incidence high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst 98: 105-109.
16. La Ruche G, You B, Mensha-Ado I, Bergeron C, Montcho C, Ramon R, et al. 1998. Human papillomavirus and human immunodeficiency virus infections: Relation with cervical dysplasia-neoplasia in African women. Int J Cancer 76: 480-486.
17. Levi JE, Kleter B, Quint WG, Fink MC, Canto CI, Matsubara R, Linhares I, Segurado A, Vanderborght B, Neto JE, Van Doorn LJ. 2002. High prevalence of human papillomavirus (HPV) infection and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 40: 3341-3345.
18. Levi JE, Fernandez S, Tateno AF, Lima LP, Eluf-Neto J, Pannuti CS, et al. 2004. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 92: 225-231.
19. Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, Rose RC, et al. 2006. Prevalence of human papillomavirus genotypes and relate abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 194: 428-434.
20. Maggwa BN, Hunter DJ, Mbugua S, Tukei P, Mati JK. 1993. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. AIDS 7: 733-738.
21. Maiman M, Frucheter RG, Clark M, Arrastia CD, Matthews R, Gates EJ. 1997. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 89: 76-80.
22. Matsushita K, Sasagawa T, Miyashita M, Ishizaki A, Morishita A, Hosaka N, Saikawa K, Hoshina S, Bi X, Ichimura H. 2011. Oral and cervical human papillomavirus infection among female sex workers in Japan. Jpn J Infect Dis 64: 34-39.
23. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
24. Muñoz N, Castellsague X, de Gonzalez AB, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24: S1-S10.
25. Nappi L, Carriero C, Bettocchi S, Herrero J, Vimercati A, Pano G. 2005. Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: Recurrence, persistence and progression, in treated and untreated women. Eur J Obstet Gynecol Reprod Biol 121: 226-232.
26. Palefsky J. 2006a. Biology of HPV in HIV infection. Adv Dent Res 19: 99-105. Review.
27. Palefsky J. 2006b. Human papillomavirus-related tumors in HIV. Curr Opin Oncol 18: 463-468.
28. Poljak M, Martin IJ, Seme K, Vince A. 2002. Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25: S89-S97.
29. Provencher D, Valme B, Averette HE, Ganjei P, Donato D, Penalver M, et al. 1988. HIV status and positive Papanicolaou screening: Identification of high-risk population. Gynecol Oncol 31: 184-188.
30. Rellihan MA, Dooley DP, Burke TW, Berkland ME, Longfield RN. 1990. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol 36: 435-438.
31. Schwartz LB, Carcangiu ML, Bradman L, Schwartz PE. 1991. Rapid progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: Clinical opinion. Gynecol Oncol 41: 255-258.
32. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Cliford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. In J Cancer 121: 621-632.
33. Smith JS, Moses S, Hudgens MG, Parker CB, Agot K, Maclean I, Ndinya-Achola JO, Snijders PJ, Meijer CJ, Bailey RC. 2010. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 201: 1677-1685.
34. Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, Quint W. 1999. Risk factors for human papillomavirus and cervical pre-cancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynecol Osbtet 65: 171-181.
35. Tweddel G, Heller P, Cunnane M, Multhaupt H, Roth K. 1994. The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol 52: 161-164.
36. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
37. Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV. 2000. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 85: 206-210.
38. Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kipto M, Nakitare GW, Ichimura H, Inoue M. 2008. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol 80: 847-855.
39. zur Hausen H. 1987. Papillomavirus in human cancer. App Pathol 5: 19-24.